Dispatch · December 18, 2025 · 6 min · By Kerensa Molyneux
PRP microneedling: the vampire facial, examined
What the much-photographed treatment actually does for skin texture, tone, and fine lines.

The vampire facial earned its lurid nickname and its celebrity photographs, but underneath the theater is a fairly sensible combination treatment. Microneedling creates thousands of controlled micro-channels in the skin to trigger collagen production; applying or injecting platelet-rich plasma at the same time floods those channels with growth factors meant to amplify the repair.
For the right concerns, the logic holds up reasonably well. Patients seeking smoother texture, softened fine lines, more even tone, and a general improvement in skin quality tend to be the better candidates. The PRP component appears to speed healing after microneedling and may modestly improve the collagen response, which is why some practices favor it over microneedling alone, particularly for acne scarring and dull, crepey skin.
The honest framing is that this is an incremental, skin-quality treatment, not a substitute for filler, resurfacing lasers, or surgery. It does not lift, fill hollows, or erase deep wrinkles. Results build over several sessions and require sun protection and patience to hold. The dramatic before-and-afters that circulate online usually reflect multiple sessions plus good skincare, not a single appointment. Used as a steady investment in skin quality rather than a one-time transformation, PRP microneedling is a credible, low-downtime option, just not the miracle the photographs imply. The same gap between promise and reality shows up in orthopedics, which we examine in PRP for joints and arthritis.
Related reading: Does PRP work for hair loss?.
Further reading: Platelet-rich plasma - A comprehensive review of isolation, activation, and application (Acta Biomater 2025); Platelet-Rich Plasma (PRP): Molecular Mechanisms, Actions and Clinical Applications in Human Body (Int J Mol Sci 2025); Platelet-rich plasma and corticosteroid injection for tendinopathy: a systematic review and meta-analysis (BMC Musculoskelet Disord 2025).